China IIT deaths prompt lawmakers to request FDA clampdownnews2026-08-21T11:00:51+00:00August 21st, 2026|Endpoints News|
Replimune lands commercial chief after hard-fought approval; Neumora’s Paul Berns sheds CEO titlenews2026-08-21T11:00:44+00:00August 21st, 2026|Endpoints News|
A mix of former Republican lawmakers and Trump admin leaders are in the race to lead PhRMAnews2026-08-20T18:26:03+00:00August 20th, 2026|Endpoints News|
Three deaths in China shake trust in its speedy clinical trial systemnews2026-08-20T18:05:41+00:00August 20th, 2026|Endpoints News|
FDA rejects Osteal combo therapy to treat joint-implant infectionsnews2026-08-20T17:38:03+00:00August 20th, 2026|Endpoints News|
Using gray-market versions of Lilly’s triple-G leads to relatively poor weight loss, study findsnews2026-08-20T15:12:43+00:00August 20th, 2026|Endpoints News|
Try first, evaluate later: How the FDA is approaching digital health devicesnews2026-08-20T14:34:02+00:00August 20th, 2026|Endpoints News|
Lilly partners with Amplitude on vaccines; Otsuka scraps psychedelic trialnews2026-08-20T14:33:30+00:00August 20th, 2026|Endpoints News|
WuXi Bio to offload chromatography unit; Cabaletta names another CDMO partner news2026-08-20T13:23:46+00:00August 20th, 2026|Endpoints News|
Epic’s AI push overlaps with health tech startupsnews2026-08-20T13:16:42+00:00August 20th, 2026|Endpoints News|
